Lonza Group AG Net Assets
Lonza Group AG net assets. Based on the latest financial reports, Lonza Group AG (LONN) has net assets worth CHF8.15 Billion CHF (≈ $10.31 Billion USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF18.26 Billion ≈ $23.08 Billion USD) and total liabilities (CHF10.11 Billion ≈ $12.78 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See how leveraged is Lonza Group AG's balance sheet to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CHF8.15 Billion |
| % of Total Assets | 44.65% |
| Annual Growth Rate | 9.82% |
| 5-Year Change | -6.47% |
| 10-Year Change | 290.11% |
| Growth Volatility | 35.59 |
Net Assets of Lonza Group AG (2004–2025)
Net assets of Lonza Group AG from 2004 to 2025. This chart illustrates how Lonza Group AG's net assets have evolved over time, based on quarterly financial data. Also explore Lonza Group AG annual equity growth to track the company's year-over-year net asset growth rate.
Annual Net Assets for Lonza Group AG (2004–2025)
The table below shows the annual net assets of Lonza Group AG from 2004 to 2025. For live market cap and overall valuation, see LONN market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CHF9.19 Billion ≈ $11.61 Billion |
-2.14% |
| 2024-12-31 | CHF9.39 Billion ≈ $11.87 Billion |
-1.30% |
| 2023-12-31 | CHF9.51 Billion ≈ $12.03 Billion |
-10.81% |
| 2022-12-31 | CHF10.66 Billion ≈ $13.48 Billion |
+8.57% |
| 2021-12-31 | CHF9.82 Billion ≈ $12.42 Billion |
+42.69% |
| 2020-12-31 | CHF6.88 Billion ≈ $8.70 Billion |
+4.86% |
| 2019-12-31 | CHF6.57 Billion ≈ $8.30 Billion |
+4.37% |
| 2018-12-31 | CHF6.29 Billion ≈ $7.95 Billion |
+1.76% |
| 2017-12-31 | CHF6.18 Billion ≈ $7.81 Billion |
+162.46% |
| 2016-12-31 | CHF2.35 Billion ≈ $2.98 Billion |
+10.30% |
| 2015-12-31 | CHF2.13 Billion ≈ $2.70 Billion |
+0.23% |
| 2014-12-31 | CHF2.13 Billion ≈ $2.69 Billion |
+0.19% |
| 2013-12-31 | CHF2.13 Billion ≈ $2.69 Billion |
-11.64% |
| 2012-12-31 | CHF2.41 Billion ≈ $3.04 Billion |
+2.12% |
| 2011-12-31 | CHF2.36 Billion ≈ $2.98 Billion |
-1.30% |
| 2010-12-31 | CHF2.39 Billion ≈ $3.02 Billion |
-0.08% |
| 2009-12-31 | CHF2.39 Billion ≈ $3.02 Billion |
+33.54% |
| 2008-12-31 | CHF1.79 Billion ≈ $2.26 Billion |
-1.05% |
| 2007-12-31 | CHF1.81 Billion ≈ $2.29 Billion |
+12.51% |
| 2006-12-31 | CHF1.61 Billion ≈ $2.03 Billion |
+7.85% |
| 2005-12-31 | CHF1.49 Billion ≈ $1.88 Billion |
+15.95% |
| 2004-12-31 | CHF1.28 Billion ≈ $1.62 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Lonza Group AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 611.9% over the analyzed period, indicating profitable operations and earnings retention.
Lonza Group AG Net Assets Breakdown (December 2025)
Lonza Group AG net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CHF9.92 Billion | 108.57% |
| Common Stock | CHF70.00 Million | 0.77% |
| Other Comprehensive Income | CHF-1.80 Billion | -19.75% |
| Other Components | CHF951.00 Million | 10.41% |
| Total Equity | CHF9.13 Billion | 100.00% |
Lonza Group AG Competitors by Market Cap
The table below lists competitors of Lonza Group AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bank of Communications Co. Ltd
F:C4C
|
$37.12 Billion |
|
KOMATSU LTD. SPONS. ADR 1
F:KOMA
|
$37.13 Billion |
|
Mahindra & Mahindra Limited
NSE:M&M
|
$37.15 Billion |
|
Endesa SA
MC:ELE
|
$37.25 Billion |
|
Galderma Group N
SW:GALD
|
$37.01 Billion |
|
PT BK CE.AS.ADR/25 RP625
F:BZG
|
$36.90 Billion |
|
Beijing-Shanghai High Speed Railway Co Ltd
SHG:601816
|
$36.87 Billion |
|
Saab AB (publ)
ST:SAAB-B
|
$36.81 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lonza Group AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 9,328,000,000 to 9,134,000,000, a change of -194,000,000 (-2.1%).
- Net loss of 275,000,000 reduced equity.
- Dividend payments of 280,000,000 reduced retained earnings.
- Share repurchases of 518,000,000 reduced equity.
- New share issuances of 11,000,000 increased equity.
- Other comprehensive income decreased equity by 529,000,000.
- Other factors increased equity by 1,397,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CHF-275.00 Million | -3.01% |
| Dividends Paid | CHF280.00 Million | -3.07% |
| Share Repurchases | CHF518.00 Million | -5.67% |
| Share Issuances | CHF11.00 Million | +0.12% |
| Other Comprehensive Income | CHF-529.00 Million | -5.79% |
| Other Changes | CHF1.40 Billion | +15.29% |
| Total Change | CHF- | -2.08% |
Book Value vs Market Value Analysis
This analysis compares Lonza Group AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.84x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 25.15x to 4.84x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | CHF25.12 | CHF631.80 | x |
| 2005-12-31 | CHF27.75 | CHF631.80 | x |
| 2006-12-31 | CHF27.24 | CHF631.80 | x |
| 2007-12-31 | CHF31.73 | CHF631.80 | x |
| 2008-12-31 | CHF31.43 | CHF631.80 | x |
| 2009-12-31 | CHF42.11 | CHF631.80 | x |
| 2010-12-31 | CHF42.01 | CHF631.80 | x |
| 2011-12-31 | CHF42.11 | CHF631.80 | x |
| 2012-12-31 | CHF42.89 | CHF631.80 | x |
| 2013-12-31 | CHF40.76 | CHF631.80 | x |
| 2014-12-31 | CHF40.81 | CHF631.80 | x |
| 2015-12-31 | CHF40.52 | CHF631.80 | x |
| 2016-12-31 | CHF44.55 | CHF631.80 | x |
| 2017-12-31 | CHF89.58 | CHF631.80 | x |
| 2018-12-31 | CHF83.21 | CHF631.80 | x |
| 2019-12-31 | CHF87.09 | CHF631.80 | x |
| 2020-12-31 | CHF91.22 | CHF631.80 | x |
| 2021-12-31 | CHF130.89 | CHF631.80 | x |
| 2022-12-31 | CHF142.51 | CHF631.80 | x |
| 2023-12-31 | CHF128.28 | CHF631.80 | x |
| 2024-12-31 | CHF130.83 | CHF631.80 | x |
| 2025-12-31 | CHF130.44 | CHF631.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lonza Group AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.01%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.21%
- • Asset Turnover: 0.34x
- • Equity Multiplier: 2.08x
- Recent ROE (-3.01%) is below the historical average (11.22%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 10.74% | 6.32% | 0.65x | 2.60x | CHF9.50 Million |
| 2005 | 12.62% | 7.46% | 0.58x | 2.91x | CHF39.00 Million |
| 2006 | 13.81% | 9.72% | 0.58x | 2.43x | CHF61.30 Million |
| 2007 | 16.65% | 10.49% | 0.58x | 2.74x | CHF120.20 Million |
| 2008 | 23.42% | 14.27% | 0.60x | 2.76x | CHF240.10 Million |
| 2009 | 6.84% | 5.91% | 0.54x | 2.13x | CHF-73.50 Million |
| 2010 | 11.90% | 10.60% | 0.56x | 2.00x | CHF45.30 Million |
| 2011 | 6.53% | 5.72% | 0.38x | 2.98x | CHF-81.70 Million |
| 2012 | 7.56% | 4.64% | 0.55x | 2.95x | CHF-58.70 Million |
| 2013 | 4.09% | 2.43% | 0.56x | 3.00x | CHF-125.60 Million |
| 2014 | 11.13% | 6.51% | 0.57x | 3.02x | CHF24.00 Million |
| 2015 | 12.97% | 7.28% | 0.61x | 2.93x | CHF63.50 Million |
| 2016 | 12.78% | 7.28% | 0.61x | 2.90x | CHF65.50 Million |
| 2017 | 11.84% | 15.96% | 0.33x | 2.26x | CHF112.70 Million |
| 2018 | 8.99% | 10.09% | 0.40x | 2.24x | CHF-62.80 Million |
| 2019 | 9.93% | 15.33% | 0.30x | 2.13x | CHF-4.40 Million |
| 2020 | 12.75% | 19.28% | 0.31x | 2.15x | CHF187.50 Million |
| 2021 | 30.19% | 54.43% | 0.33x | 1.69x | CHF1.97 Billion |
| 2022 | 11.47% | 19.52% | 0.36x | 1.64x | CHF155.30 Million |
| 2023 | 6.92% | 9.74% | 0.40x | 1.78x | CHF-291.20 Million |
| 2024 | 6.82% | 11.61% | 0.28x | 2.12x | CHF-296.80 Million |
| 2025 | -3.01% | -4.21% | 0.34x | 2.08x | CHF-1.19 Billion |
Industry Comparison
This section compares Lonza Group AG's net assets metrics with peer companies in the Diagnostics & Research industry.
No peer company data available for comparison.
About Lonza Group AG
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biol… Read more